The Claim
Inositol hexaphosphate (IP6) at a dose of 600 mg twice daily for two weeks is associated with a statistically significant reduction in fasting serum uric acid in asymptomatic hyperuricemic adults.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking 600 mg of inositol hexaphosphate twice daily for two weeks is linked to a measurable decrease in fasting uric acid levels in adults with elevated uric acid but no symptoms of gout.
See the scientific wording
Inositol hexaphosphate (IP6) at a dose of 600 mg twice daily for two weeks is associated with a statistically significant reduction in fasting serum uric acid in asymptomatic hyperuricemic adults, but the clinical relevance and safety beyond this short duration remain unknown.
When inositol hexaphosphate is taken by mouth, it binds to purine molecules in the gut, preventing them from being absorbed into the bloodstream. With fewer purines reaching the liver, less uric acid is made, which lowers the amount of uric acid in the blood.
What the research says
1 studyTaking IP6 pills twice a day for two weeks lowered uric acid levels in people with high levels, just like the claim says. But we don’t know yet if it’s safe or helpful for longer than two weeks.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.